Acute peripheral vertigo. Benign paroxysmal vertigo
Conditions
Interventions
Intervention 1: Intervention 1:
Patients with acute peripheral vertigo enroll to the study considering inclusion and exclusion criteria. First arm, include 35 patients who receive 5 mg of intravenous
Treatment - Drugs
Intervention 1:
Patients with acute peripheral vertigo enroll to the study considering inclusion and exclusion criteria. First arm, include 35 patients who receive 5 mg of intravenous diazepam. The p
Intervention 2:
Patients with acute peripheral vertigo enroll to the study considering inclusion and exclusion criteria. First arm, include 35 patients who receive 12.5 mg of intramuscular promethaz
Sponsors
Vice chancellor for research,Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: aged between 18-60 years old; acute peripheral vertigo and ataxia. exclusion criteria: history of syncope or cardiac event; considerations of a central origin for vertigo; focal neurological deficits; known pregnancy; evidence of drug-induced vertigo or orthostatic hypotension; known dystonic or adverse reaction to diazepam and promethazine or other similar agents; report of taking medication within 24 hours of ED presentation that might affect the results (e.g., antihistamines, antipsychotics, opioid analgesics or sedatives).
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Ataxia. Timepoint: 60 and 120 minutes after intervention. Method of measurement: Romberg Test and tandem gait test. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood pressure. Timepoint: 60 and 120 minutes after intervention. Method of measurement: Sphygmomanometer.;Heart Rate. Timepoint: 60 and 120 minutes after intervention. Method of measurement: Pulse oximetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Vakili
Arak University of Medical Sciences
Outcome results
None listed